Efficacy and safety of continuing sitagliptin when initiating insulin therapy in subjects with type 2 diabetes

被引：0
|
作者：
Roussel, R. [1 ]
Duran-Garcia, S. [2 ]
Zhang, Y. [3 ]
Shah, S. [3 ]
Darmiento, C. [3 ]
Shankar, R. R. [3 ]
O'Neill, E. A. [3 ]
Golm, G. T. [3 ]
Lam, R. L. H. [3 ]
Gantz, I. [3 ]
Kaufman, K. D. [3 ]
Engel, S. S. [3 ]
机构：
[1] Grp Hosp Bichat, Paris, France
[2] Valme Univ Hosp, Med Sch, Seville, Spain
[3] Merck & Co Inc, Kenilworth, NJ USA
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
770
引用
收藏
页码：S378 / S378
页数：1
相关论文
共 50 条
  • [11] Efficacy and Safety of Sitagliptin in the Treatment of Type 2 Diabetes
    Gadsby, Roger
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 53 - 62
  • [12] Initiating and Intensifying Insulin Therapy for Type 2 Diabetes: Why, When, and How
    Cobble, Michael E.
    AMERICAN JOURNAL OF THERAPEUTICS, 2009, 16 (01) : 56 - 64
  • [13] Double-blind, randomized clinical trial comparing the efficacy and safety of continuing or discontinuing the dipeptidyl peptidase-4 inhibitor sitagliptin when initiating insulin glargine therapy in patients with type 2 diabetes: The CompoSIT-I Study
    Roussel, Ronan
    Duran-Garcia, Santiago
    Zhang, Yilong
    Shah, Suneri
    Darmiento, Carolyn
    Shankar, R. Ravi
    Golm, Gregory T.
    Lam, Raymond L. H.
    O'Neill, Edward A.
    Gantz, Ira
    Kaufman, Keith D.
    Engel, Samuel S.
    DIABETES OBESITY & METABOLISM, 2019, 21 (04): : 781 - 790
  • [14] Safety and efficacy of sitagliptin and metformin when used as initial combination therapy to treat hyperglycaemia in patients with type 2 diabetes
    不详
    DIABETES OBESITY & METABOLISM, 2008, 10 (01): : 97 - 97
  • [15] Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patients
    Kubota, Akira
    Maeda, Hajime
    Kanamori, Akira
    Matoba, Kiyokazu
    Jin, Yasuyuki
    Minagawa, Fuyuki
    Obana, Mitsuo
    Iemitsu, Kotaro
    Ito, Shogo
    Amamiya, Hikaru
    Kaneshiro, Mizuki
    Takai, Masahiko
    Kaneshige, Hideaki
    Hoshino, Kazuhiko
    Ishikawa, Masashi
    Minami, Nobuaki
    Takuma, Tetsuro
    Sasai, Nobuo
    Aoyagi, Sachio
    Kawata, Takehiro
    Mokubo, Atsuko
    Takeda, Hiroshi
    Honda, Shin
    Machimura, Hideo
    Motomiya, Tetsuya
    Waseda, Manabu
    Naka, Yoshikazu
    Tanaka, Yasushi
    Terauchi, Yasuo
    Matsuba, Ikuro
    JOURNAL OF DIABETES INVESTIGATION, 2012, 3 (06) : 503 - 509
  • [16] Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes
    Raz, Itamar
    Chen, Yu
    Wu, Mei
    Hussain, Shehla
    Kaufman, Keith D.
    Amatruda, John M.
    Langdon, Ronald B.
    Stein, Peter P.
    Alba, Maria
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (02) : 537 - 550
  • [17] Efficacy and Safety of Switching from Basal Insulin to Sitagliptin in Japanese Type 2 Diabetes Patients
    Harashima, S. -I.
    Tanaka, D.
    Yamane, S.
    Ogura, M.
    Fujita, Y.
    Murata, Y.
    Seike, M.
    Koizumi, T.
    Aono, M.
    Wang, Y.
    Inagaki, N.
    HORMONE AND METABOLIC RESEARCH, 2013, 45 (03) : 231 - 238
  • [18] Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy
    Shimoda, Seiya
    Iwashita, Shinsuke
    Ichimori, Shinji
    Matsuo, Yasuto
    Goto, Rieko
    Maeda, Takako
    Matsuo, Tomoko
    Sekigami, Taiji
    Kawashima, Junji
    Kondo, Tatsuya
    Matsumura, Takeshi
    Motoshima, Hiroyuki
    Furukawa, Noboru
    Nishida, Kenro
    Araki, Eiichi
    ENDOCRINE JOURNAL, 2013, 60 (10) : 1207 - 1214
  • [19] Efficacy and safety of sitagliptin added to treatment of patients with type 2 diabetes inadequately controlled with premixed insulin
    Yu, Miao
    Shankar, R. Ravi
    Zhang, Ruya
    Zhang, Ye
    Lin, Jianxin
    O'Neill, Edward A.
    Chen, Guojuan
    Liu, Shu
    Tu, Yingmei
    Engel, Samuel S.
    DIABETES OBESITY & METABOLISM, 2019, 21 (02): : 408 - 411
  • [20] Efficacy and Safety of Sitagliptin Therapy Compared with Pioglitazone in Heart Failure Patients with Type 2 Diabetes
    Naka, Toshio
    Akagami, Takafumi
    Doi, Takashi
    Masuyama, Tohru
    Ohyanagi, Mitsumasa
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (10) : S188 - S188
12345